Trial Profile
Intradermal influenza vaccine for older adults: A randomixed controlled multicenter phase III study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 06 Feb 2014
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Influenza virus vaccine
- Indications Influenza virus infections
- Focus Pharmacodynamics; Registrational
- Sponsors Sanofi; Sanofi Pasteur
- 09 Dec 2009 Status changed from active, no longer recruiting to completed according to results published in Vaccine
- 09 Dec 2009 Results have been published in the journal Vaccine.
- 09 Dec 2009 Primary endpoints 'Geometric mean antibody titre' and 'Seroprotection rate' have been met according to results published in Vaccine.